The Shift from AI to ALife, and the Potential of BioArt
NQ Score
50/100
AI Summary (NQ-processed)
Transeeds Inc. shares its 'April Dream' vision, projecting a future where Artificial Life (ALife) driven by biotechnology succeeds AI, revolutionizing art and entertainment through the science collective LOM BABY.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is LOM BABY?
- A: A science collective hosted by Transeeds, composed of artists and scientists, focusing on the theme of 'the birth of life'.
- Q: What is the purpose of this announcement?
- A: As part of the 'April Dream' project, it shares a visionary dream of future entertainment using Artificial Life and biotechnology succeeding AI.
- Q: What are Transeeds' upcoming plans?
- A: From 2026 to 2027, they plan to announce new bio-products in collaboration with global IPs and fashion brands.